Video

Researchers: More Apples-to-Apples Comparisons Needed


 

At a recent briefing, researchers cited their studies as examples of the advantages of comparative effectiveness research. One study, for example, questioned the effectiveness of proton therapy for the treatment of prostate cancer. Another found that using the monoclonal antibody bevacizumab (Avastin) as a first-line chemotherapy treatment did not improve outcomes for elderly patients with advanced lung cancer.

Recommended Reading

Nearly Half of States Implementing Health Reform
MDedge Hematology and Oncology
Supreme Court Justices Skeptical on Individual Mandate
MDedge Hematology and Oncology
Justices Hint at Striking Entire Affordable Care Act
MDedge Hematology and Oncology
ACA Could Surface as Issue in Wisconsin Primary
MDedge Hematology and Oncology
Chemotherapy Less Costly in Physician Office Than in Hospital
MDedge Hematology and Oncology
HHS Calls for 1-Year Delay for ICD-10
MDedge Hematology and Oncology
First Medicare ACOs Sign the Dotted Line
MDedge Hematology and Oncology
Use of Ultrasound Expands Across Surgical Specialties
MDedge Hematology and Oncology
Implementing Health Reform: Physician Compare
MDedge Hematology and Oncology
Beyond Cash: Using Rewards to Motivate Physicians
MDedge Hematology and Oncology

Related Articles